Related Experiment Video
Updated: Apr 27, 2026
07:17
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.8K
Multiple halo naevi associated with tocilizumab.
1Department of Dermatology, Chapel Allerton Hospital, Leeds, West Yorkshire, UK.
Clinical and Experimental Dermatology
|July 3, 2014
Summary
Tocilizumab treatment for juvenile idiopathic arthritis (JIA) was associated with the development of halo nevi. This suggests interleukin-6 (IL-6) signaling may influence melanocyte function and immune responses.
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- Tocilizumab targets the interleukin-6 (IL-6) receptor, approved for rheumatoid arthritis and juvenile idiopathic arthritis (JIA).
- Interleukin-6 (IL-6) is a cytokine implicated in cancer immunity and melanocyte function, with elevated levels observed in vitiligo.
Observation:
- A case of multiple halo nevi developed in a patient with a history of JIA undergoing tocilizumab treatment.
- Halo nevi are benign lesions characterized by a depigmented halo surrounding a central nevus.
Findings:
- Tocilizumab's mechanism may involve immune system modulation, potentially leading to halo nevus formation.
- Altered epidermal cytokine profiles due to increased serum IL-6 levels from tocilizumab could directly inhibit melanocytes.
Implications:
- This case highlights a potential dermatological side effect of tocilizumab therapy.
- Further research is warranted to elucidate the precise role of IL-6 in melanocyte biology and immune-related dermatoses.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:19Hypersensitivity Reactions: Immune-Complex Reactions
261
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
261
01:01Hypersensitivity Reactions: Cytolytic Reactions
205
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
205
01:21Cytotoxic Edema: Pathophysiology
19
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
19
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:29Autoimmune Disorders
2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K